---
doc_id: TBD
title: "Clinical Evaluation Procedure"
doc_type: "Procedure"
process: "design-and-develop-products"
owner: TBD
status: Draft
version: "0.1"
effective_date: TBD
---

# Clinical Evaluation Procedure

## 1. Introduction
### 1.1 Purpose
This procedure defines the requirements and process for planning, conducting, and documenting clinical evaluation activities to demonstrate safety and performance of medical devices.


### 1.2 Scope
This procedure applies to all clinical evaluation activities required for medical device conformity assessment under MDR. This procedure covers clinical evaluation plans, reports, and post-market clinical follow-up activities.


### 1.3 Responsibilities
[To be defined by the organization]

### 1.4 Reference Standards, Regulations or Guides
- ISO 13485:2016 — Clauses 7.3, 7.1
- MDR Annex XIV
- MDCG 2020-1

### 1.5 Reference Documents
- Product Design and Development Procedure
- Risk Management Procedure
- PMS / Vigilance Procedures
- Clinical templates

## 2. Terminology
[To be defined by the organization]

## 3. Procedure
This section describes the clinical evaluation process for planning, conducting, and documenting clinical evaluation activities to demonstrate medical device safety and performance. The process covers clinical evaluation planning, evidence collection and appraisal, reporting, and post-market clinical follow-up.


## 4. Records
[To be defined by the organization]

## 5. Retention
[To be defined by the organization]

## 6. Access Control
[To be defined by the organization]

---

This document is provided as part of the Git-native eQMS framework developed by **QARA PULSE**.

It is shared under the terms of the Apache License, Version 2.0.
You may use, modify, and distribute this document in accordance with the License.

This template provides structure only. Regulatory compliance depends on proper implementation
by the organization.

Framework developed by QARA PULSE — *We don't build medtechs. We build infrastructure for medtechs to grow.*
